Paolo Lopedote, Geoffrey Shouse, Sandrine Puverel, Alexandra Muir, Carly Roleder, Peter Sportelli, Hari Miskin, Lu Chen, Tycel J Phillips, Alexey V Danilov
{"title":"阿卡拉布替尼、umbralisib和ublituximab的无化疗方案在未经治疗的套细胞淋巴瘤患者中获得了高缓解率和检测不到的微小残留疾病。","authors":"Paolo Lopedote, Geoffrey Shouse, Sandrine Puverel, Alexandra Muir, Carly Roleder, Peter Sportelli, Hari Miskin, Lu Chen, Tycel J Phillips, Alexey V Danilov","doi":"10.1111/bjh.20041","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":" ","pages":""},"PeriodicalIF":5.1000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A chemotherapy-free regimen of acalabrutinib, umbralisib and ublituximab achieved high response rates and undetectable minimal residual disease in patients with untreated mantle cell lymphoma.\",\"authors\":\"Paolo Lopedote, Geoffrey Shouse, Sandrine Puverel, Alexandra Muir, Carly Roleder, Peter Sportelli, Hari Miskin, Lu Chen, Tycel J Phillips, Alexey V Danilov\",\"doi\":\"10.1111/bjh.20041\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":135,\"journal\":{\"name\":\"British Journal of Haematology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2025-04-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Haematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/bjh.20041\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Haematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bjh.20041","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
A chemotherapy-free regimen of acalabrutinib, umbralisib and ublituximab achieved high response rates and undetectable minimal residual disease in patients with untreated mantle cell lymphoma.
期刊介绍:
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.